First Time Loading...

SANUWAVE Health Inc
OTC:SNWV

Watchlist Manager
SANUWAVE Health Inc Logo
SANUWAVE Health Inc
OTC:SNWV
Watchlist
Price: 0.0216 USD 5.37%
Updated: Mar 28, 2024

Intrinsic Value

SNWV's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. [ Read More ]

The intrinsic value of one SNWV stock under the Base Case scenario is 0.0762 USD. Compared to the current market price of 0.0216 USD, SANUWAVE Health Inc is Undervalued by 72%.

Key Points:
SNWV Intrinsic Value
Base Case
0.0762 USD
Undervaluation 72%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
SANUWAVE Health Inc

Backtest SNWV Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling SNWV stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Financials

Balance Sheet Decomposition
SANUWAVE Health Inc

Current Assets 7.4m
Cash & Short-Term Investments 1.1m
Receivables 3.2m
Other Current Assets 3.1m
Non-Current Assets 12.9m
PP&E 1.1m
Intangibles 11.9m
Current Liabilities 85.4m
Accounts Payable 4.6m
Accrued Liabilities 12.5m
Short-Term Debt 27.3m
Other Current Liabilities 41m
Non-Current Liabilities 862k
Other Non-Current Liabilities 862k
Efficiency

Earnings Waterfall
SANUWAVE Health Inc

Revenue
18.9m USD
Cost of Revenue
-5.6m USD
Gross Profit
13.3m USD
Operating Expenses
-17.9m USD
Operating Income
-4.6m USD
Other Expenses
-47.6m USD
Net Income
-52.2m USD

Free Cash Flow Analysis
SANUWAVE Health Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

SNWV Profitability Score
Profitability Due Diligence

SANUWAVE Health Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional ROE
ROE is Increasing
39/100
Profitability
Score

SANUWAVE Health Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

SNWV Solvency Score
Solvency Due Diligence

SANUWAVE Health Inc's solvency score is 16/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Positive Net Debt
Short-Term Solvency
16/100
Solvency
Score

SANUWAVE Health Inc's solvency score is 16/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SNWV Price Targets Summary
SANUWAVE Health Inc

There are no price targets for SNWV.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

SNWV Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

SNWV Price
SANUWAVE Health Inc

1M 1M
-18%
6M 6M
+14%
1Y 1Y
-13%
3Y 3Y
-87%
5Y 5Y
-88%
10Y 10Y
-97%
Annual Price Range
0.0216
52w Low
0.01
52w High
0.042
Price Metrics
Average Annual Return -20.86%
Standard Deviation of Annual Returns 42.48%
Max Drawdown -100%
Shares Statistics
Market Capitalization 24.6m USD
Shares Outstanding 1 140 560 000
Percentage of Shares Shorted
N/A

SNWV Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

SANUWAVE Health Inc Logo
SANUWAVE Health Inc

Country

United States of America

Industry

Health Care

Market Cap

24.6m USD

Dividend Yield

0%

Description

SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. The company is headquartered in Suwanee, Georgia and currently employs 43 full-time employees. The company went IPO on 2008-11-07. The firm's is focused on regenerative medicine utilizing noninvasive, acoustic shock waves to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body’s normal healing processes and regeneration. The firm's lead regenerative product in the United States is the dermaPACE device, used for treating diabetic foot ulcers. The company intends to apply its Pulsed Acoustic Cellular Expression (PACE) technology in wound healing, orthopedic, plastic/cosmetic and cardiac conditions.

Contact

GEORGIA
Suwanee
3360 Martin Farm Rd Ste 100
+17704197525.0
http://sanuwave.com/

IPO

2008-11-07

Employees

43

Officers

CEO & Chairman
Mr. Morgan C. Frank
Chief Strategic Officer & Director
Mr. Kevin A. Richardson II
President
Mr. Andrew Walko
Chief Financial Officer
Dr. Toni Rinow M.B.A., Ph.D.
Chief Operation Officer
Mr. Peter Stegagno
Chief Science & Technology Officer
Dr. Iulian Cioanta
Show More
Executive VP of Sales for U.S. Wound Business
Mr. Tim Hendricks
Show Less

See Also

Discover More
What is the Intrinsic Value of one SNWV stock?

The intrinsic value of one SNWV stock under the Base Case scenario is 0.0762 USD.

Is SNWV stock undervalued or overvalued?

Compared to the current market price of 0.0216 USD, SANUWAVE Health Inc is Undervalued by 72%.